Risk of nevirapine-associated Stevens-Johnson syndrome among HIV-infected pregnant women: the Medunsa National Pharmacovigilance Centre, 2007 - 2012
- PMID: 23971123
- DOI: 10.7196/samj.6077
Risk of nevirapine-associated Stevens-Johnson syndrome among HIV-infected pregnant women: the Medunsa National Pharmacovigilance Centre, 2007 - 2012
Abstract
Background: Stevens-Johnson syndrome (SJS) is an acute life-threatening condition often elicited by drugs. The government's indecisiveness in deciding to stop the use of nevirapine (NVP) in HIV-infected pregnant women owing to the increase of SJS among this population group in South Africa prompted this investigation.
Objectives: To investigate if pregnancy is a risk factor for SJS among HIV-infected women taking NVP-containing regimens and registered within the Medunsa National Pharmacovigilance Centre database.
Methods: A matched case-control study with 5:1 matching was conducted. Women with SJS (cases) taking NVP-containing regimens were matched with women without SJS (controls) taking NVP-containing regimens. Controls were randomly selected and matched to cases by hospital, age, treatment duration and CD4 count. Conditional logistic regression was used to determine if pregnancy was a risk factor for SJS.
Results: Six SJS cases were identified and 30 controls selected. The median age of both cases and controls was 29 years and the average CD4 counts were 237 and 234 cells/microl respectively. Subjects were on NVP treatment for 18 - 31 days before the onset of SJS. Controls did not develop SJS after treatment of between 1 and 365 days. Pregnancy increased the chances of developing SJS 14-fold (OR 14.28, p = 0.006, 95% CI 1.54 - 131.82).
Conclusions: NVP-containing ARV regimens taken during pregnancy increase the risk of developing SJS. Healthcare workers are advised to offer informed consent to patients and recommend effective contraception methods if NVP treatment is considered. In the light of our findings, further studies of the association between NVP, pregnancy and SJS are necessary before general conclusions can be reached.
Similar articles
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394 Review.
-
Stevens-Johnson syndrome associated with nevirapine use in an HIV-positive pregnant woman: a case report.West Afr J Med. 2010 May-Jun;29(3):187-9. West Afr J Med. 2010. PMID: 20665464
-
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Review.
-
Nevirapine toxicity in a cohort of HIV-1-infected pregnant women.Am J Obstet Gynecol. 2006 Jan;194(1):199-202. doi: 10.1016/j.ajog.2005.05.015. Am J Obstet Gynecol. 2006. PMID: 16389032
-
Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.AIDS. 2001 Sep 28;15(14):1843-8. doi: 10.1097/00002030-200109280-00014. AIDS. 2001. PMID: 11579247
Cited by
-
Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients.Front Med (Lausanne). 2023 May 5;10:1118527. doi: 10.3389/fmed.2023.1118527. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37215719 Free PMC article.
-
Antiretroviral Options and Treatment Decisions During Pregnancy.Paediatr Drugs. 2023 May;25(3):267-282. doi: 10.1007/s40272-023-00559-w. Epub 2023 Feb 2. Paediatr Drugs. 2023. PMID: 36729360 Review.
-
HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and Hypersensitivity.J Invest Dermatol. 2023 Mar;143(3):362-373. doi: 10.1016/j.jid.2022.07.035. Epub 2022 Dec 20. J Invest Dermatol. 2023. PMID: 36549954 Free PMC article. Review.
-
Toxic Epidermal Necrolysis in Pregnancy due to Ondansetron with a Favorable Outcome: A Case Report and Review of the Literature.J Clin Aesthet Dermatol. 2021 May;14(5):46-49. Epub 2021 May 1. J Clin Aesthet Dermatol. 2021. PMID: 34188749 Free PMC article.
-
Epilepsy management in pregnant HIV+ women in sub-Saharan Africa, clinical aspects to consider: a scoping review.BMC Med. 2020 Nov 17;18(1):341. doi: 10.1186/s12916-020-01799-0. BMC Med. 2020. PMID: 33198766 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials